270
Participants
Start Date
November 30, 2007
Primary Completion Date
December 31, 2008
Study Completion Date
February 28, 2014
Abatacept
Solution in pre-filled syringes, Subcutaneously, 125 mg, Weekly, (Short Term (3 periods - 12 weeks each; Long Term)
Placebo
Solution in pre-filled syringes, Subcutaneously, 0 mg, Weekly, Period II 12 weeks (Short Term)
Local Institution, Capital Federal
Local Institution, Rosario
Local Institution, Santa Fe
Local Institution, Berea
Local Institution, Córdoba
Local Institution, Panorama
Local Institution, Bloemfontein
Center For Assessment And Research Of Erie, Erie
Altoona Center For Clinical Research, Duncansville
East Penn Rheumatology Associates, Bethlehem
Klein And Associates, M.D., Pa, Cumberland
Mountain State Clinical Research, Clarksburg
Columbia Arthritis Center, Columbia
Sarasota Arthritis Research Center, Sarasota
Local Institution, León
Diagnostic Rheumatology And Research,Pc, Indianapolis
Local Institution, Metepec
St. Paul Rheumatology, P.A., Eagan
Albuquerque Clinical Trials, Inc., Albuquerque
Wallace Rheumatic Study Center, Los Angeles
Local Institution, Mérida
New England Research Associates, Llc, Trumbull
Clinical Pharmacology Study Group, Worcester
Local Institution, Trois-Rivières
Local Institution, Mexico City
Local Institution, Muckleneuk
Local Institution, Pretoria
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY